Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > Record Q1 results:

<< Previous

Bullboard Posts

Next >>

Comment by wizzdumbon Feb 10, 2022 7:33am

143 Views

Post# 34415567

RE:Record Q1 results:

Good results and very nice margins, but unfortunately nothing that's going to get anyone excited. We will continue to plod along until big news or drastic change in visibility or market sentiment. Looking forward to Mondays call.

<< Previous

Bullboard Posts

Next >>

Investing with insurance and protection